serw-MX  [xml]  
 


    
 DeCS Categories

C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.470 Neoplasms, Glandular and Epithelial .
C04.557.470.035 Adenoma .
C04.557.470.035.100 Adenoma, Islet Cell .
C04.557.470.035.100.852 Insulinoma .
C04.588 Neoplasms by Site .
C04.588.274 Digestive System Neoplasms .
C04.588.274.761 Pancreatic Neoplasms .
C04.588.274.761.249 Adenoma, Islet Cell .
C04.588.274.761.249.500 Insulinoma .
C04.588.322 Endocrine Gland Neoplasms .
C04.588.322.475 Pancreatic Neoplasms .
C04.588.322.475.249 Adenoma, Islet Cell .
C04.588.322.475.249.500 Insulinoma .
C06 Digestive System Diseases .
C06.301 Digestive System Neoplasms .
C06.301.761 Pancreatic Neoplasms .
C06.301.761.249 Adenoma, Islet Cell .
C06.301.761.249.500 Insulinoma .
C06.689 Pancreatic Diseases .
C06.689.667 Pancreatic Neoplasms .
C06.689.667.249 Adenoma, Islet Cell .
C06.689.667.249.500 Insulinoma .
C10 Nervous System Diseases .
C10.597 Neurologic Manifestations .
C10.597.606 Neurobehavioral Manifestations .
C10.597.606.358 Consciousness Disorders .
C10.597.606.358.800 Unconsciousness .
C10.597.606.358.800.200 Coma 2461 .
C10.597.606.358.800.200.600 Insulin Coma .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.394 Glucose Metabolism Disorders .
C18.452.394.984 Hypoglycemia .
C18.452.394.984.492 Insulin Coma .
C19 Endocrine System Diseases .
C19.344 Endocrine Gland Neoplasms .
C19.344.421 Pancreatic Neoplasms .
C19.344.421.249 Adenoma, Islet Cell .
C19.344.421.249.500 Insulinoma .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.472 Hormones .
D06.472.699 Peptide Hormones .
D06.472.699.587 Pancreatic Hormones .
D06.472.699.587.200 Insulins .
D06.472.699.587.200.500 Proinsulin .
D06.472.699.587.200.500.625 Insulin .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.277 Hydrolases .
D08.811.277.656 Peptide Hydrolases .
D08.811.277.656.300 Endopeptidases .
D08.811.277.656.300.480 Metalloendopeptidases .
D08.811.277.656.300.480.300 Insulysin .
D08.811.277.656.675 Metalloproteases .
D08.811.277.656.675.374 Metalloendopeptidases .
D08.811.277.656.675.374.300 Insulysin .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.548 Peptide Hormones .
D12.644.548.586 Pancreatic Hormones .
D12.644.548.586.200 Insulins .
D12.644.548.586.200.500 Proinsulin .
D12.644.548.586.200.500.625 Insulin .
HP4 Materia Medica .
HP4.018 Homeopathic Remedy .
HP4.018.375 Homeopathic Remedy I .
HP4.018.375.508 Insulinum .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Insulins .
Peptide hormones that cause an increase in the absorption of GLUCOSE by cells within organs such as LIVER, MUSCLE and ADIPOSE TISSUE. During normal metabolism insulins are produced by the PANCREATIC BETA CELLS in response to increased GLUCOSE. Natural and chemically-modified forms of insulin are also used in the treatment of GLUCOSE METABOLISM DISORDERS such as DIABETES MELLITUS. .
1.00
9196
 
Insulin .
Iletin .
Insulin A Chain .
Insulin B Chain .
Insulin, Regular .
Novolin .
Sodium Insulin .
Soluble Insulin .
Chain, Insulin B .
Insulin, Sodium .
Insulin, Soluble .
Regular Insulin .
A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). .
0.99
1505166018
 
Insulysin .
Insulin Protease .
Insulin Proteinase .
Insulin-Degrading Enzyme .
Enzyme, Insulin-Degrading .
Insulin Degrading Enzyme .
Protease, Insulin .
Proteinase, Insulin .
Insulinase .
An enzyme the catalyzes the degradation of insulin, glucagon and other polypeptides. It is inhibited by bacitracin, chelating agents EDTA and 1,10-phenanthroline, and by thiol-blocking reagents such as N-ethylmaleimide, but not phosphoramidon. (Eur J Biochem 1994;223:1-5) EC 3.4.24.56. .
0.88
1609
 
Insulinum .
Homeopathic remedy. Abbrev.: "ins.". Animal origin. Substance used: pancreas hormone. .
0.87
00
 
Insulinoma .
Adenoma, beta Cell .
Adenomas, beta-Cell .
Insulinomas .
Insulomas .
Tumor, beta-Cell .
Tumors, beta-Cell .
beta Cell Tumor .
beta-Cell Adenoma .
beta-Cell Adenomas .
beta-Cell Tumors .
Insuloma .
beta-Cell Tumor .
Adenoma, beta-Cell .
A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA. .
0.86
1364222
 
Insulin Coma .
Insulin Shock .
Coma, Insulin .
Shock, Insulin .
Severe HYPOGLYCEMIA induced by a large dose of exogenous INSULIN resulting in a COMA or profound state of unconsciousness from which the individual cannot be aroused. .
0.78
2295